IceCure Medical Receives Notice of Intention to Grant a European Patent Covering Its Cryogenic Pump
December 20, 2021
CAESAREA, Israel, December 20, 2021 — IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) (“IceCure” or the “Company”), developer of minimally-invasive cryoablation technology, the ProSense® System,